4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001780081-25-000006
Director sold 40,472 shares at $29.72 ($1,202,719)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Krainer Adrian R. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-24 | Sale : show line 1 in the form 10b5-1 | −40,472 | $29.72 | $1,202,719 | 323,774 | D |
| Open-market sales · 40,472 sh · avg $29.72 · $1,202,719 | ||||||
Loading xslF345X05/form4-11262025_091144.xml…